These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


121 related items for PubMed ID: 961829

  • 1. Animal model of human disease: adenosis and clear-cell carcinomas of vagina and cervix.
    Forsberg JG.
    Am J Pathol; 1976 Sep; 84(3):669-72. PubMed ID: 961829
    [No Abstract] [Full Text] [Related]

  • 2. Clear cell carcinoma of the cervix and vagina in young women. A report of six cases with association of maternal stilbestrol therapy and adenosis of the vagina.
    Hill EC.
    Am J Obstet Gynecol; 1973 Jun 15; 116(4):470-84. PubMed ID: 4709483
    [No Abstract] [Full Text] [Related]

  • 3. Clear cell carcinoma of the cervix and vagina in young women. A report of six cases with association of maternal stilbestrol therapy and adenosis of the vagina.
    Hill EC.
    Trans Pac Coast Obstet Gynecol Soc; 1972 Jun 15; 40():15-29. PubMed ID: 4668177
    [No Abstract] [Full Text] [Related]

  • 4. Intrauterine diethylstilbestrol exposure and its consequences: pathologic characteristics of vaginal adenosis, clear cell adenocarcinoma, and related lesions.
    Robboy SJ, Scully RE, Welch WR, Herbst AL.
    Arch Pathol Lab Med; 1977 Jan 15; 101(1):1-5. PubMed ID: 576195
    [Abstract] [Full Text] [Related]

  • 5. Topographic relation of cervical ectropion and vaginal adenosis to clear cell adenocarcinoma.
    Robboy SJ, Welch WR, Young RH, Truslow GY, Herbst AL, Scully RE.
    Obstet Gynecol; 1982 Nov 15; 60(5):546-51. PubMed ID: 6890656
    [Abstract] [Full Text] [Related]

  • 6. Adenocarcinoma of the vagina in young women. The stilbestrol-adenosis-adenocarcinoma of the vagina syndrome.
    Fetherston WC, Meyers A, Speckhard ME.
    Wis Med J; 1972 Feb 15; 71(2):87-93. PubMed ID: 5060564
    [No Abstract] [Full Text] [Related]

  • 7. Transition of benign vaginal adenosis to clear cell carcinoma.
    Ghosh TK, Cera PJ.
    Obstet Gynecol; 1983 Jan 15; 61(1):126-30. PubMed ID: 6823342
    [Abstract] [Full Text] [Related]

  • 8. Post-stilbestrol secondary syndrome.
    Pomerance W.
    Obstet Gynecol; 1973 Jul 15; 42(1):12-8. PubMed ID: 4720194
    [No Abstract] [Full Text] [Related]

  • 9. Vaginal adenosis, dysplasia, and clear cell adenocarcinoma after diethylstilbestrol treatment in pregnancy.
    Barber HR, Sommers SC.
    Obstet Gynecol; 1974 May 15; 43(5):645-52. PubMed ID: 4822648
    [No Abstract] [Full Text] [Related]

  • 10. Atypical vaginal adenosis and cervical ectropion. Association with clear cell adenocarcinoma in diethylstilbestrol-exposed offspring.
    Robboy SJ, Young RH, Welch WR, Truslow GY, Prat J, Herbst AL, Scully RE.
    Cancer; 1984 Sep 01; 54(5):869-75. PubMed ID: 6537153
    [Abstract] [Full Text] [Related]

  • 11. Vaginal adenosis and adenocarcinoma in mice exposed prenatally or neonatally to diethylstilbestrol.
    Newbold RR, McLachlan JA.
    Cancer Res; 1982 May 01; 42(5):2003-11. PubMed ID: 7066910
    [Abstract] [Full Text] [Related]

  • 12. Complications of systemic oral contraceptive therapy: Neoplasm--breast, uterus, cervix and vagina.
    Sperling MA.
    West J Med; 1975 Jan 01; 122(1):42-9. PubMed ID: 1089006
    [No Abstract] [Full Text] [Related]

  • 13. Vaginal and cervical abnormalities, including clear-cell adenocarcinoma, related to prenatal exposure to stilbestrol.
    Scully RE, Robboy SJ, Herbst AL.
    Ann Clin Lab Sci; 1974 Jan 01; 4(4):222-33. PubMed ID: 4460850
    [Abstract] [Full Text] [Related]

  • 14. Cervical-vaginal adenosis after in utero exposure to synthetic estrogens.
    Sherman AI, Goldrath M, Berlin A, Vakhariya V, Banooni F, Michaels W, Goodman P, Brown S.
    Obstet Gynecol; 1974 Oct 01; 44(4):531-45. PubMed ID: 4412373
    [Abstract] [Full Text] [Related]

  • 15. Clinical diagnosis of vaginal adenosis.
    Stafl A, Mattingly RF, Foley DV, Fetherston WC.
    Obstet Gynecol; 1974 Jan 01; 43(1):118-28. PubMed ID: 4808952
    [Abstract] [Full Text] [Related]

  • 16. Pathology of vaginal and cervical abnormalities associated with prenatal exposure to diethylstilbestrol (des).
    Robboy SJ, Scully RE, Herbst AL.
    J Reprod Med; 1975 Jul 01; 15(1):13-18. PubMed ID: 1151939
    [No Abstract] [Full Text] [Related]

  • 17. Localization of 3H-estradiol-17beta in diethylstilbestrol-induced adenosis.
    Kalland T, Fossberg TM, Forsberg JG.
    Obstet Gynecol; 1978 Apr 01; 51(4):464-7. PubMed ID: 662230
    [Abstract] [Full Text] [Related]

  • 18. Treatment of clear cell adenocarcinoma in young females.
    Wharton JT, Rutledge FN, Gallager HS, Fletcher G.
    Obstet Gynecol; 1975 Apr 01; 45(4):365-8. PubMed ID: 1121369
    [Abstract] [Full Text] [Related]

  • 19. Pathologic findings in young women enrolled in the National Cooperative Diethylstilbestrol Adenosis (DESAD) project.
    Robboy SJ, Kaufman RH, Prat J, Welch WR, Gaffey T, Scully RE, Richart R, Fenoglio CM, Virata R, Tilley BC.
    Obstet Gynecol; 1979 Mar 01; 53(3):309-17. PubMed ID: 424102
    [No Abstract] [Full Text] [Related]

  • 20. Transition of vaginal adenosis to clear cell carcinoma.
    Sandberg EC.
    Obstet Gynecol; 1984 Apr 01; 63(4):601-2. PubMed ID: 6700910
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.